Could a TB vaccine help control type 1 diabetes?
NCT ID NCT02081326
First seen Dec 16, 2025 · Last updated May 29, 2026 · Updated 28 times
Summary
This study tests whether repeated doses of the BCG vaccine (originally for tuberculosis) can lower blood sugar levels in adults with type 1 diabetes. The trial involves 150 participants and lasts 10 years, with results expected to show if BCG can help control diabetes without relying on the pancreas. It also explores protection against infections like COVID-19.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for COVID19 are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Immunobiology Labs CNY 149
Charlestown, Massachusetts, 02129, United States
Conditions
Explore the condition pages connected to this study.